Table 1.
Correlation of the expression of LINC01123 in NSCLC with clinicopathologic features
| Characteristics | LINC01123 | P value | ||
|---|---|---|---|---|
| Low and negative (n) | High (n) | |||
| Age (years) | ||||
| < 55 | 32 (34.8%) | 17 | 15 | 0.827 |
| ≥ 55 | 60 (65.2%) | 29 | 31 | |
| Gender | ||||
| Male | 51 (55.4%) | 26 | 25 | 0.500 |
| Female | 41 (44.6%) | 20 | 21 | |
| TNM stage | ||||
| I | 49 (53.3%) | 32 | 17 | 0.001** |
| II | 19 (20.7) | 10 | 9 | |
| III | 22 (23.9%) | 4 | 18 | |
| IV | 2 (2.2%) | 0 | 2 | |
| T stage | ||||
| T1 | 37 (40.2%) | 21 | 16 | 0.002** |
| T2 | 37 (40.2%) | 21 | 16 | |
| T3 | 11 (12.0%) | 3 | 8 | |
| T4 | 7 (7.6%) | 1 | 6 | |
| Lymph node metastasis | ||||
| N0 | 55 (59.8%) | 33 | 22 | 0.002** |
| N1 | 22 (23.9%) | 9 | 13 | |
| N2 | 11 (12.0%) | 4 | 7 | |
| N3 | 4 (4.3%) | 0 | 4 | |
| Distant metastasis | ||||
| M0 | 90 (97.8%) | 46 | 44 | 0.495 |
| M1 | 2 (2.2%) | 0 | 2 | |
| Mortality | ||||
| Survive | 41 (44.6%) | 27 | 14 | 0.011* |
| Die | 51 (55.4%) | 19 | 32 | |
| Histological grade | ||||
| I | 2 (2.2%) | 2 | 0 | 0.467 |
| II | 57 (62.0%) | 25 | 32 | |
| III | 33 (35.9%) | 19 | 14 | |
| Tumor location | ||||
| Left | 43 (46.7%) | 24 | 19 | 0.454 |
| Right | 49 (53.3%) | 22 | 27 | |
*P < 0.05; **P < 0.01